Regulation of Cell Signaling by Mig6 and Sprouty2 in Cancers With Egfr MutationsAlice M. Walsh(BioScience Laboratories (United States))ScholarlyCommons (University of Pennsylvania)January 1, 2014Cited by 0SaveCiteExport RISWatch citationsRelated PapersClinical Validation of <i>PBRM1</i> Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma|JAMA Oncology|2019|242